Sfoglia per AUTORE
CELSA C
Collezione AO Ordine Mauriziano
Items : 2
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial. in ESMO open / ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27.
2025
AO Ordine Mauriziano
AO Ordine Mauriziano
Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison. in Annals of surgery / Ann Surg. 2022 Apr 1;275(4):743-752. doi: 10.1097/SLA.0000000000005373.
2022
AO Ordine Mauriziano
AO Ordine Mauriziano
Famularo S; Donadon M; Cipriani F; Giuliante F; Ferri S; Celsa C; Ferrero A; Foschi FG; Baiocchi GL; Biasini E; Campani C; Valle RD; Pelizzaro F; Baroni GS; Raimondo G; Mega A; Chiarelli M; Maestri M; Gasbarrini A; Jovine E; Grazi GL; Rapaccini GL; Ruzzenente A; Morisco F; Sacco R; Memeo R; Crespi M; Antonucci A; Bernasconi DP; et alii...